the aid library

LIST OPTIONS

Filter

4693

Priority medical devices list for the COVID-19 response and associated technical specifications (Arab Version)
recommended

World Health Organization WHO (2021) C_WHO

23 February 2021 This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc... more

Download (412)

View PDF (412)

Integrated Care for Older People (ICOPE) - A manual for nurses - Trainee´s handbook

World Health Organization WHO (2020) C_WHO

This manual will aid in building the capacity of nurses with clinical knowledge of the unique needs, complex health problems, common geriatric syndromes, and principles of care of older people. It will also enable them to acquire the skills necessary to perform an in-depth multidimensional geriatric... more

Download (439)

View PDF (509)

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS
recommended

African Union; Africa CDC Centres for Disease Control and Prevention; AMREF; ASLM; et al. (2021) CC

ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr... more

Download (433)

View PDF (647)

Management of the sick young infant aged up to 2 months. Facilitator Guide
recommended

World Health Organization WHO (2019) C_WHO

Integrated management of childhood illness. The last update was in the IMCI chart booklet in 2014, but since then there have been significant updates on the management of sick young infant (SYI) aged up to 2 months. This 2019 update of the sick young infant section Management of the sick young infan... more

Download (959)

View PDF (1336)

WHO Expert Consultation on Rabies. 3rd report

Abela-Ridder, B. World Health Organisation (WHO) (2018) C_WHO

WHO TRS N°1012. Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite... more

Download (423)

View PDF (721)

Measures to strengthen primary health-care systems in low- and middle-income countries

Etienne V Langlois, Andrew Mc Kenzie, Helen Schneider & Jeffrey W Mecaskey World Health Organization (2020) C_WHO

Primary health care offers a cost–effective route to achieving universal health coverage (UHC). However, primary health-care systems are weak in many low- and middle-income countries and often fail to provide comprehensive, people-centred, integrated care. We analysed the primar... more

Download (946)

View PDF (1525)

Security Management and Capacity Development: International agencies working with local partners

Singh, Iesha; European Interagency Security Forum (EISF) (2012) C2

This EISF report provides an analysis of the issues surrounding the relationship between NGO’s and their local partners. It includes a section on the topic and its background, responsabilities towards the partner organisation and particularly in terms of security, how to enable and help the partne... more

Download (432)

View PDF (603)

Epilepsy care guidelines for low- and middle-income countries: From WHO mental health GAP to national programs

J. Katchanov; G. L. Birbeck BMC Medicine (2012) CC

BMC Medicine201210:107 https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012 Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012 In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r... more

External Link

Measuring effective coverage of curative child health services in rural Burkina Faso: a cross-sectional study

Koulidiati J. L., Nesbitt R. C., Ouedraogo N. et. al. BMJ Open (2018) C2

BMJ Open2018;8:e020423. doi:10.1136/bmjopen-2017-02042 EC has been increasingly used in the evaluation of maternal and child health programmes.12–15 For instance, Nesbitt et al compared crude coverage and EC of pregnant women with facility-based obstetric services in Ghana and estimated that alth... more

Download (464)

View PDF (635)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (388)

View PDF (488)

COVID-19 Vaccination, Country Readiness and Delivery: Supply and Logistics Guidance
recommended

World Health Organization WHO; UNICEF (2020) C_WHO

Working Document Nov. 2020 The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup... more

Download (393)

View PDF (611)

Public financial management for effective response to health emergencies

World Health Organization WHO (2022) C_WHO

The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r... more

Download (855)

View PDF (838)

WHO good manufacturing practices for pharmaceutical products: main principles

World Health Organization WHO (2014) C_WHO

Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,... more

Download (196)

View PDF (144)

Political economy analysis for health financing: A ‘how to’ guide

World Health Organization (WHO) (2024) CC

This Guide is part of WHO’s overall programme of work on Political Economy of Health Financing Reform: Analysis and Strategy to Support UHC. The impetus for this work came from demands for more concrete evidence, recognition and integration of political economy issues within health financing, and... more

Download (151)

View PDF (110)

Integrated Management of Malaria Training - Health Workers Manual

The Ruepublic of Uganda - Ministry of Health (2019) C2

The "Integrated Management of Malaria Training – Health Worker’s Manual" is a practical guide developed by Uganda’s Ministry of Health to train healthcare workers at all levels in the effective diagnosis, treatment, prevention, and management of malaria. It aligns with national malaria treatme... more

Download (104)

View PDF (73)

Standards for Providing Quality R Palliative Care Across Africa

African Palliative Care Association APCA (2011) C2

The African Palliative Care Association is pleased to publish the first edition of Palliative Care Standards for Africa. The development of these standards was achieved through wide consultation with service beneficiaries and providers, and they have been developed to suit different levels of ... more

Download (399)

View PDF (378)

Exploration of Community Health Workers’ views about in their role and support in Primary Health Care in Northern Cape, South Africa

Ramukumba, M.M. Journal of Community Health (2019) CC

Community health workers (CHWs) play a significant role in Primary health Care due to their proximity to households, communities and the health care system. Many studies focus on CHWs and the work they do. However, few have examined their experiences and identity and how that might influence how the... more

Download (486)

View PDF (442)

C1. Déficience intellectuelle

Xiaoyan Ke & Jing Liu IACAPAP (2015) C1

retard mental, est définie comme un arrêt du développement mental ou un développement mental incomplet, caractérisé essentiellement par une insuffisance des facultés qui déterminent le niveau global d’intelligence, c’est-à-dire les fonctions cognitives, le langage, la motricité et l... more

Download (361)

View PDF (618)

Health in the green economy : health co-benefits of climate change mitigation - transport sector

World Health Organization (WHO) (2012) C_WHO

The threat climate change poses to health, equity, and development has been rigorously documented. However, in an era marked by economic crisis, regional conflicts, natural disasters and growing disparities between rich and poor, the joint global actions required to address climate change have been ... more

Download (465)

View PDF (413)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

Priority medical devices list for the COVID-19 response and associated technical specifications (Arab Version) recommended

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS recommended

Management of the sick young infant aged up to 2 months. Facilitator Guide recommended

COVID-19 Vaccination, Country Readiness and Delivery: Supply and Logistics Guidance recommended

Priority medical devices list for the COVID-19 response and associated technical specifications (Arab Version)
recommended

Cadre de l'Assurance Qualité Test de Diagnostic Rapide de l'Antigene COV-2-SARS
recommended

Management of the sick young infant aged up to 2 months. Facilitator Guide
recommended

COVID-19 Vaccination, Country Readiness and Delivery: Supply and Logistics Guidance
recommended